OBD was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases.
Registrars:
Key Personnel
Non-Executive Director:
Stephen Charles Diggle, Peter Presland
Executive Chairman:
Iain Ross
Chief Executive Officer :
Jon Burrows
Independent Non-Executive Director:
David Holbrook
Chief Scientific Officer:
Alexandre Akoulitchev
CFO & Executive Director:
Paul Stockdale
Contact Details
Address:
3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, United Kingdom